Access Bio, Inc. (KOSDAQ:950130)
2,285.00
+95.00 (4.34%)
Jul 21, 2026, 3:30 PM KST
Access Bio Market Cap
Access Bio has a market cap or net worth of 80.37 billion as of July 21, 2026. Its market cap has decreased by -57.21% in one year.
Market Cap
80.37B
Enterprise Value
-251.21B
Revenue
14.94B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,285.00
ChartMarket Cap Chart
Since May 30, 2013, Access Bio's market cap has decreased from 269.10B to 80.37B, a decrease of -70.13%. That is a compound annual growth rate of -8.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 80.37B | -39.87% |
| Dec 30, 2025 | 133.66B | -26.78% |
| Dec 30, 2024 | 182.55B | -39.72% |
| Dec 28, 2023 | 302.84B | -26.91% |
| Dec 29, 2022 | 414.36B | -27.26% |
| Dec 30, 2021 | 569.63B | -27.38% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| T&R Biofab | 99.14B |
| Osang Healthcare Co.,Ltd | 81.98B |
| DRTECH | 81.56B |
| Ray Co., Ltd. | 75.54B |
| Sugentech | 61.39B |
| P&S Robotics | 59.14B |
| LabGenomics | 53.38B |
| Humasis | 49.67B |